Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
March 25, 2026
March 25, 2026
ROCHESTER, Minnesota, March 25 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
*
ROCHESTER, Minn. - Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped prevent and detect it before spreading, major . . .
* * *
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
*
ROCHESTER, Minn. - Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped prevent and detect it before spreading, major . . .